Structure-based design of a B cell antigen from B. pseudomallei

Area of Science:

• Microbiology
• Immunology
• Structural Biology

Background:

• Melioidosis, caused by Burkholderia pseudomallei, is a severe endemic disease in Southeast Asia with high mortality rates.
• Current diagnostic and treatment strategies for melioidosis are largely ineffective, necessitating urgent development of new tools.

Purpose of the Study:

• To identify and characterize novel targets for immunodiagnostic and vaccine development against Burkholderia pseudomallei.
• To explore the potential of BPSL1050 as a candidate for new melioidosis diagnostic and prophylactic tools.

Main Methods:

• Utilized reverse and structural vaccinology approaches to identify BPSL1050.
• Determined the NMR solution structure and dynamics of BPSL1050.
• Employed computational methods to predict immunogenic epitopes and synthesized them for antibody elicitation.

Main Results:

• BPSL1050 showed reactivity with sera from melioidosis patients.
• Synthesized epitopes elicited antibodies that caused bacterial agglutination.
• These antibodies recognized both BPSL1050 and crude Burkholderia pseudomallei extracts.

Conclusions:

• BPSL1050 is a promising candidate for developing novel immunodiagnostic and vaccine strategies against melioidosis.
• The findings support the use of chemical biology approaches for discovering new tools against B. pseudomallei infections.
• This research paves the way for improved diagnostic and prophylactic measures for melioidosis.